Malaysia is expected to receive its first shipment of the Covid-19 oral antiviral treatment, Paxlovid by Pfizer, in two weeks, said Health Minister Khairy Jamaluddin.

He said for the first phase of the procurement, Malaysia had purchased 110,000 patient courses (for 110,000 patients) to be given to high-risk individuals.